Enzene will be participating in CPHI Worldwide 2025 and welcomes the opportunity to engage with global partners exploring CDMO services and biosimilar collaborations.
Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.